New user? Sign up here |

HIV and Pregnancy: Patient on Biktarvy - Therapeutic Options

Details

Starts at: August 5, 2022 9:00am ET
Ends at: August 5, 2022 9:45am ET
Free Admission

Description

SA patient with HIV (hx of Atripla use, switched to Dovato and then given Biktarvy) - patient now pregnant. Discussion of therapeutic option for ART as well as use of Biktarvy vs. Dovato. 

Targeted Populations

A variety of the listed populations will be discussed at this event.

  • Black or African American
  • Women

Materials

Topics

A variety of the listed topics will be discussed at this event.

  • HIV Transmission Risk Assessment
  • Prevention of perinatal or mother-to-child transmission
  • Adult and adolescent antiretroviral treatment
  • Antiretroviral treatment adherence, including viral load suppression
  • HIV diagnosis (i.e. HIV testing)
  • HIV monitoring and lab tests (i.e. CD4 ad viral load)
  • Hepatitis B
  • Hepatitis C
  • Immunization
  • Sexually transmitted infections
  • Substance use disorders
  • Health insurance coverage (i.e. Affordable Care Act, health insurance exchanges, managed care)
  • Use of technology (i.e. electronic health records)